On Nov. 19, the U.S. Food and Drug Administration (FDA) allowed marketing of four diagnostic devices that can be used for high throughput gene sequencing, often referred to as “next generation sequencing” (NGS). Read more.
FDA allows marketing of ‘next generation’ gene sequencing devices
Author(s):
Most Recent Content
For Nurse Practitioners
Cup of Coffee Can Lessen Gestational Diabetes Risk
Pregnant mothers concerned about being able to safely enjoy their morning cup of coffee should be reassured by a recent University of Pennsylvania study...
